Table 3

Overall of assessments used in COPD-ICP implementation study

DomainType of assessment/outcomesPre-ICP implementationPost-ICP implementationConcurrent comparator group in COPD disease management registry
Baseline demographicsAge, race, gender, nationality, postal code
DiseaseDisease type, disease duration
Social-economicsMedisave, Medifund, Medical social worker referral
Programme managementProgramme enrolment date✓(baseline)xx
Quality of lifeCAT score✓(baseline)x
Smoking historySmoking status, number of years of smoking
Key care elementsRefer to table 1✓(baseline)
Disease severity (based on medication use)Refer to the 2011 GOLD guidelines summary9
Comorbidities and complicationAsthma
Depression
Congestive heart failure
Diabetes
Hypertension
CKD stage 3–5
Stroke
Dyslipidaemia
Obesity
Others
COPD-related health service utilisationHospitalisation, average length of stay
Number of encountersEmergency department attendance
Specialist outpatient visit
Primary care visit
COPD-related cost (DRG)Direct cost
Indirect cost
MortalityRate of mortality
Qualitative measuresPatient assessment of chronic illness carex
  • CAT, COPD assessment test; CKD, chronic kidney disease; COPD-ICP, chronic obstructive pulmonary disease-integrated care pathway; DRG, diagnosis-related group.